Charles S. Ryan - Aug 20, 2024 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
PRESIDENT
Signature
/s/ Brendan Hannah, Attorney-in-Fact
Stock symbol
QNCX
Transactions as of
Aug 20, 2024
Transactions value $
$31,452
Form type
4
Date filed
8/22/2024, 05:51 PM
Previous filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Purchase $31.5K +48.4K +65.32% $0.65 122K Aug 20, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.62 to $0.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.